Want to see JP:3636 full AI Analyst Report?
3636 Stock Chart & Stats
¥4860.00
-¥5.00(-0.10%)
At close: 4:00 PM EST
¥4860.00
-¥5.00(-0.10%)
Day’s Range― - ―
52-Week Range¥4,375.00 - ¥5,360.00
Previous CloseN/A
Volume35.50K
Average Volume (3M)33.73K
Market Cap
¥83.12B
Enterprise Value¥38.21B
Total Cash (Recent Filing)¥41.91B
Total Debt (Recent Filing)¥982.00M
Price to Earnings (P/E)10.0
Beta0.69
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.14%
Share Statistics
EPS (TTM)525.61
Shares Outstanding16,044,000
10 Day Avg. Volume39,440
30 Day Avg. Volume33,733
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)1.13
Price to Sales (P/S)0.67
P/FCF Ratio29.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)435.05
Revenue Forecast (FY)¥131.12B
Bulls Say, Bears Say
Bulls Say
Revenue And Margin GrowthThe combination of renewed revenue growth and improving gross margin indicates that MRI is expanding while managing delivery costs effectively. Positive EBIT and EBITDA margin trends support more durable operating efficiency, strengthening its ability to fund services, technology investment, and future growth.
Conservative Balance SheetMinimal leverage gives MRI substantial financial resilience and flexibility. A strong equity base reduces dependence on borrowing, limits interest-related pressure, and leaves the company better positioned to sustain investment in consulting capabilities and IT solutions through changing demand conditions.
Healthy Operating Cash FlowHealthy operating cash flow and stable conversion relative to net income show that reported profitability is supported by cash generation. This provides an important foundation for ongoing operations and investment, while reducing reliance on external financing to support the business.
Bears Say
Lower Return On EquityA declining return on equity suggests MRI is generating somewhat less profit from its equity base than before. If this persists, it could indicate less efficient capital deployment and may constrain improvement in shareholder returns even while the balance sheet remains financially strong.
Weaker Free Cash Flow GrowthThe deterioration in free cash flow growth and conversion could reduce the cash available for investment, dividends, or strategic initiatives. Even with healthy operating cash flow, sustained weakness in free cash flow would make the company less effective at translating earnings into financial flexibility.
Demand And Project ExposureMRI's fee-based research, consulting, and IT project revenue depends on continued demand from government programs and corporate transformation initiatives. Changes in program priorities or project activity could make revenue growth less predictable across the next several quarters.
Mitsubishi Research Institute News
3636 FAQ
What was Mitsubishi Research Institute’s price range in the past 12 months?
Mitsubishi Research Institute lowest stock price was ¥4375.00 and its highest was ¥5360.00 in the past 12 months.
What is Mitsubishi Research Institute’s market cap?
Mitsubishi Research Institute’s market cap is ¥83.12B.
When is Mitsubishi Research Institute’s upcoming earnings report date?
Mitsubishi Research Institute’s upcoming earnings report date is Nov 04, 2026 which is in 13 days.
How were Mitsubishi Research Institute’s earnings last quarter?
Mitsubishi Research Institute released its earnings results on Jul 29, 2026. The company reported -¥100.96 earnings per share for the quarter.
Is Mitsubishi Research Institute overvalued?
According to Wall Street analysts Mitsubishi Research Institute’s price is currently Overvalued.
Does Mitsubishi Research Institute pay dividends?
Mitsubishi Research Institute pays a Semiannually dividend of ¥85 which represents an annual dividend yield of 3.14%. See more information on Mitsubishi Research Institute dividends here
What is Mitsubishi Research Institute’s EPS estimate?
Mitsubishi Research Institute’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mitsubishi Research Institute have?
Mitsubishi Research Institute has 16,044,000 shares outstanding.
What happened to Mitsubishi Research Institute’s price movement after its last earnings report?
Mitsubishi Research Institute reported an EPS of -¥100.96 in its last earnings report. Following the earnings report the stock price went up 2.758%.
Which hedge fund is a major shareholder of Mitsubishi Research Institute?
Currently, no hedge funds are holding shares in JP:3636
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mitsubishi Research Institute
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, financial organizations, and private corporations. The company's extensive solutions span areas such as management consultation, digital and financial innovation, environmental and energy initiatives, healthcare and wellness, regional development, future infrastructure deployment, scientific and safety research, nuclear safety, and broad economic, social, and R&D initiatives. Furthermore, MRI handles specialized project engagements and public sector procurement. In a key collaboration, it partners with ForePaaS SAS to implement cloud-native data-intensive solutions across Japan. Established in 1970, Mitsubishi Research Institute, Inc. is headquartered in Tokyo.